Vimarsana
Biggest News Aggregation in the World

First Preclinical Data News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from First Preclinical Data. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In First Preclinical Data Today - Breaking & Trending Today

Beam Therapeutics Presents Preclinical Data Highlighting Utility of BEAM-302 to Correct an Alpha-1 Antitrypsin (AAT) Deficiency Disease-Causing Mutation - Vimarsana News

Beam Therapeutics Presents Preclinical Data Highlighting Utility of BEAM-302 to Correct an Alpha-1 Antitrypsin (AAT) Deficiency Disease-Causing Mutation

Published: September 7, 2023

First Preclinical Data for BEAM-302 Demonstrate Increased Levels of Corrected AAT and Reduced Mutant PiZ AAT in Multiple In Vivo Rodent Disease ModelsCAMBRIDGE, Mass., Sept. 07, 2023 -- Beam...

Source: marketscreener.com
Related Topics:
United StatesUnited KingdomChelcie ListerGiuseppe CiaramellaDan BudwickBeam Therapeutics IncStrategic CommunicationsExchange CommissionFirst Preclinical DataIncreased LevelsReduced Mutant PizMultiple In Vivo Rodent DiseaseLung DiseasePrivate Securities Litigation Reform ActAnnual ReportQuarterly Report
Investegate |Centessa Pharmaceuticals plc Announcements | Centessa Pharmaceuticals plc: Centessa Pharmaceuticals Announces Poster Presentation of First Preclinical Data for LockBody® Program at 2022 ASCO Annual Meeting - Vimarsana News

Investegate |Centessa Pharmaceuticals plc Announcements | Centessa Pharmaceuticals plc: Centessa Pharmaceuticals Announces Poster Presentation of First Preclinical Data for LockBody® Program at 2022 ASCO Annual Meeting

Published: June 5, 2022

Investegate announcements from Centessa Pharmaceuticals plc, Centessa Pharmaceuticals Announces Poster Presentation of First Preclinical Data for LockBody® Program at 2022 ASCO Annual Meeting

Source: investegate.co.uk
Related Topics:
United StatesCity OfUnited KingdomSaurabh SahaKristenk SheppardAntoine YverExchange CommissionAmerican Society Of Clinical OncologyResearch DevelopmentCentessa PharmaceuticalsDevelopment At CentessaFirst Preclinical DataClinical OncologyAnnual MeetingDevelopmental TherapeuticsChief Executive OfficerQuarterly ReportVice President InvestorInvestegate AnnouncementsInvestegate Company AnnouncementsCentessa Pharmaceuticals PlcLobenewswire And Globenewswire